Biolase Inc
(BIOLQ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,930 | 6,532 | 4,181 | 9,960 | 19,549 |
| Receivables | 5,717 | 5,158 | 5,841 | 4,846 | 6,081 |
| Inventories | 13,330 | 17,775 | 15,884 | 16,427 | 16,573 |
| TOTAL | $28,147 | $31,964 | $28,959 | $33,881 | $44,267 |
| Non-Current Assets | |||||
| PPE Net | 6,371 | 4,719 | 4,278 | 3,915 | 1,373 |
| Intangibles | 2,926 | 2,926 | 2,926 | 2,926 | 2,926 |
| Other Non-Current Assets | 2,189 | 2,335 | 2,023 | 2,143 | 2,288 |
| TOTAL | $11,486 | $9,980 | $9,227 | $8,984 | $6,587 |
| Total Assets | $39,633 | $41,944 | $38,186 | $42,865 | $50,854 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,100 | 1,400 | 700 | N/A | N/A |
| Accounts payable and accrued liabilities | 6,314 | 7,540 | 5,786 | 4,974 | 4,961 |
| Accrued Expenses | 7,734 | 7,977 | 9,210 | 6,919 | 6,498 |
| TOTAL | $18,384 | $18,999 | $17,807 | $13,763 | $13,951 |
| Non-Current Liabilities | |||||
| Long Term Debt | 11,902 | 12,496 | 13,091 | 12,793 | 12,730 |
| Deferred Revenues | 2,236 | 2,082 | 2,111 | 1,870 | 2,492 |
| Other Non-Current Liabilities | 1,695 | 1,936 | 1,981 | 2,104 | 2,233 |
| TOTAL | $13,908 | $14,787 | $15,490 | $15,244 | $15,288 |
| Total Liabilities | $32,292 | $33,786 | $33,297 | $29,007 | $29,239 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,044 | 277 | 263 | 71 | 69 |
| Common Shares | 1 | 26 | N/A | 7 | 7 |
| Retained earnings | -306,885 | -302,017 | -296,168 | -286,307 | -277,920 |
| Other shareholders' equity | 106 | -653 | -733 | -1,038 | -886 |
| TOTAL | $7,341 | $8,158 | $4,889 | $13,858 | $21,615 |
| Total Liabilities And Equity | $39,633 | $41,944 | $38,186 | $42,865 | $50,854 |